A switch to Raltegravir improves antiretroviral associated hepatotoxicity in individuals co-infected with HIV and hepatitis C
Autor: | Cevik, M., Katsarolis, I., Singh, G.J., Nelson, M. |
---|---|
Zdroj: | In Journal of Infection August 2014 69(2):190-193 |
Databáze: | ScienceDirect |
Externí odkaz: |